At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ECOR Electrocore LLC
Market Closed 10-04 16:00:00 EDT
7.35
-0.04
-0.54%
盘后7.35
+0.000.00%
16:01 EDT
High7.60
Low7.32
Vol27.74K
Open7.39
D1 Closing7.39
Amplitude3.79%
Mkt Cap47.38M
Tradable Cap32.71M
Total Shares6.45M
T/O206.42K
T/O Rate0.62%
Tradable Shares4.45M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
electroCore to Participate in Upcoming Investor Conferences
electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults; Truvaga for the support of general health and wellbeing; and TAC-STIM, a form of nVNS for human performance. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.